Literature DB >> 29791651

Relationship between adiponectin and leptin on osteocalcin in obese adolescents during weight loss therapy.

Raquel Munhoz da Silveira Campos1, Deborah Cristina Landi Masquio2, Flávia Campos Corgosinho3, Joana Pereira de Carvalho-Ferreira4, Bárbara Dal Molin Netto5, Ana Paula Grotti Clemente6, Lian Tock7, Sergio Tufik8, Marco Túlio de Mello5,8,9, Ana Raimunda Dâmaso5.   

Abstract

OBJECTIVES: Obesity is a multifactorial disease characterized by the presence of the pro-inflammatory state associated with the development of many comorbidities, including bone turnover marker alterations. This study aimed to investigate the role of the inflammatory state on bone turnover markers in obese adolescents undergoing interdisciplinary weight loss treatment for one year. SUBJECTS AND METHODS: Thirty four post-pubescent obese adolescents with primary obesity, a body mass index (BMI) greater than > 95th percentile of the CDC reference growth charts, participated in the present investigation. Measurements of body composition, bone turnover markers, inflammatory biomarkers and visceral and subcutaneous fat were taken. Adolescents were submitted to one year of interdisciplinary treatment (clinical approach, physical exercise, physiotherapy intervention, nutritional and psychological counseling).
RESULTS: Reduction in body mass, body fat mass, visceral and subcutaneous fat, as well as, an increase in the body lean mass and bone mineral content was observed. An improvement in inflammatory markers was seen with an increase in adiponectin, adiponectin/leptin ratio and inteleukin-15. Moreover, a positive correlation between the adiponectin/leptin ratio and osteocalcin was demonstrated. Further, both lean and body fat mass were predictors of osteocalcin. Negative associations between leptin with osteocalcin, adiponectin with Beta CTX-collagen, and visceral fat with adiponectin were observed.
CONCLUSIONS: It is possible to conclude that the inflammatory state can negatively influence the bone turnover markers in obese adolescents. In addition, the interdisciplinary weight loss treatment improved the inflammatory state and body composition in obese adolescents. Therefore, the present findings should be considered in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29791651     DOI: 10.20945/2359-3997000000039

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  6 in total

1.  Factors associated with osteocalcin in men with spinal cord injury: findings from the FRASCI study.

Authors:  Ricardo A Battaglino; Nguyen Nguyen; Megan Summers; Leslie R Morse
Journal:  Spinal Cord       Date:  2019-07-12       Impact factor: 2.772

Review 2.  The effect of exercise training on osteocalcin, adipocytokines, and insulin resistance: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Gh R Mohammad Rahimi; A Niyazi; S Alaee
Journal:  Osteoporos Int       Date:  2020-08-15       Impact factor: 4.507

Review 3.  Adiponectin signalling in bone homeostasis, with age and in disease.

Authors:  Jonathan W Lewis; James R Edwards; Amy J Naylor; Helen M McGettrick
Journal:  Bone Res       Date:  2021-01-07       Impact factor: 13.567

4.  Semi-intensive and Intensive Interdisciplinary Treatments Have Similar Effects on Metabolic Syndrome and Selected Inflammatory Markers in Adolescents with Obesity.

Authors:  Luzia Jaeger Hintze; Ana Claudia Pelissari Kravchychyn; Yasmin Alaby Martins Ferreira; Raquel Munhoz da Silveira Campos; Alexandre D Aguilera Dantas; Deborah Cristina Landi Masquio; Danielle Arisa Caranti; David Thivel; Ana R Dâmaso
Journal:  J Obes Metab Syndr       Date:  2021-12-30

Review 5.  The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture.

Authors:  Bingzi Dong; Ruolin Lv; Jun Wang; Lin Che; Zhongchao Wang; Zhouyang Huai; Yangang Wang; Lili Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

6.  The relationship between changes in serum myostatin and adiponectin levels in patients with obesity undergoing a weight loss program.

Authors:  Nana Takao; Satoshi Kurose; Takumi Miyauchi; Katsuko Onishi; Atsuko Tamanoi; Ryota Tsuyuguchi; Aya Fujii; Sawako Yoshiuchi; Kazuhisa Takahashi; Hiromi Tsutsumi; Yutaka Kimura
Journal:  BMC Endocr Disord       Date:  2021-07-08       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.